BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Seres Therapeutics

Seres Therapeutics logo

United States of America based

Seres Therapeutics has built a proprietary discovery and design platform that enables us to understand the dysbiosis associated with specific diseases, and to rationally design tailored therapies to establish a healthy microbiome. We draw upon the disciplines of systems biology and comparative genomics—as well as our expertise in isolating and characterizing microbes that have been historically difficult to cultivate—to create a new class of therapies aimed at establishing a healthy microbiome. We compare a vast trove of human data from relevant disease states with that from healthy individuals to characterize specific microbiome functions that are disrupted in states of dysbiosis.


Microbiome Startups  

Posts Mentioning This Company

Biopharma Insights

R&D Platform



No pipelines published yet




No services posted yet